$HSTM
HealthStream Inc

2014 Q2 Form 10-Q Financial Statement

#000119312514289585 Filed on July 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $42.48M $31.92M
YoY Change 33.07% 23.52%
Cost Of Revenue $18.74M $12.87M
YoY Change 45.58% 26.6%
Gross Profit $23.74M $19.05M
YoY Change 24.62% 21.53%
Gross Profit Margin 55.89% 59.68%
Selling, General & Admin $12.61M $10.27M
YoY Change 22.84% 30.31%
% of Gross Profit 53.13% 53.9%
Research & Development $4.294M $2.778M
YoY Change 54.57% 27.31%
% of Gross Profit 18.09% 14.58%
Depreciation & Amortization $2.722M $1.897M
YoY Change 43.49% 20.67%
% of Gross Profit 11.47% 9.96%
Operating Expenses $16.91M $13.05M
YoY Change 29.6% 29.66%
Operating Profit $4.110M $4.106M
YoY Change 0.1% 1.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $23.00K $28.00K
YoY Change -17.86% 7.69%
Pretax Income $4.133M $4.134M
YoY Change -0.02% 1.65%
Income Tax $1.769M $1.712M
% Of Pretax Income 42.8% 41.41%
Net Earnings $2.364M $2.422M
YoY Change -2.39% -0.21%
Net Earnings / Revenue 5.57% 7.59%
Basic Earnings Per Share $0.09 $0.09
Diluted Earnings Per Share $0.08 $0.09
COMMON SHARES
Basic Shares Outstanding 27.57M shares 26.72M shares
Diluted Shares Outstanding 28.04M shares 27.65M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $111.8M $101.4M
YoY Change 10.23% 10.37%
Cash & Equivalents $60.86M $54.65M
Short-Term Investments $50.90M $46.78M
Other Short-Term Assets $4.038M $3.007M
YoY Change 34.29% -57.65%
Inventory
Prepaid Expenses
Receivables $29.79M $21.78M
Other Receivables $0.00 $0.00
Total Short-Term Assets $160.4M $129.8M
YoY Change 23.58% 9.24%
LONG-TERM ASSETS
Property, Plant & Equipment $9.468M $7.491M
YoY Change 26.39% 8.57%
Goodwill $43.23M $29.43M
YoY Change 46.89%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $961.0K $758.0K
YoY Change 26.78% 51.6%
Total Long-Term Assets $81.02M $56.11M
YoY Change 44.39% 29.29%
TOTAL ASSETS
Total Short-Term Assets $160.4M $129.8M
Total Long-Term Assets $81.02M $56.11M
Total Assets $241.4M $185.9M
YoY Change 29.86% 14.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.319M $1.605M
YoY Change -17.82% 33.75%
Accrued Expenses $9.338M $8.530M
YoY Change 9.47% 29.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $75.05M $40.00M
YoY Change 87.62% 19.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $615.0K $675.0K
YoY Change -8.89% -32.5%
Total Long-Term Liabilities $615.0K $675.0K
YoY Change -8.89% -32.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $75.05M $40.00M
Total Long-Term Liabilities $615.0K $675.0K
Total Liabilities $75.66M $40.67M
YoY Change 86.02% 14.57%
SHAREHOLDERS EQUITY
Retained Earnings -$13.11M -$21.48M
YoY Change -38.95%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $157.2M $138.7M
YoY Change
Total Liabilities & Shareholders Equity $241.4M $185.9M
YoY Change 29.86% 14.6%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $2.364M $2.422M
YoY Change -2.39% -0.21%
Depreciation, Depletion And Amortization $2.722M $1.897M
YoY Change 43.49% 20.67%
Cash From Operating Activities $12.91M $7.500M
YoY Change 72.13% 35.87%
INVESTING ACTIVITIES
Capital Expenditures -$2.540M -$1.440M
YoY Change 76.39% -36.0%
Acquisitions
YoY Change
Other Investing Activities -$8.300M $4.240M
YoY Change -295.75% -1384.85%
Cash From Investing Activities -$10.85M $2.790M
YoY Change -488.89% -208.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -240.0K 470.0K
YoY Change -151.06% 291.67%
NET CHANGE
Cash From Operating Activities 12.91M 7.500M
Cash From Investing Activities -10.85M 2.790M
Cash From Financing Activities -240.0K 470.0K
Net Change In Cash 1.820M 10.76M
YoY Change -83.09% 250.49%
FREE CASH FLOW
Cash From Operating Activities $12.91M $7.500M
Capital Expenditures -$2.540M -$1.440M
Free Cash Flow $15.45M $8.940M
YoY Change 72.82% 15.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27570462 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54651000
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27570000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27570000 shares
CY2014Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9338000
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23958000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1319000
CY2014Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
15838000
CY2014Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
11157000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13113000
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
51595000
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12517000
CY2014Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
181000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
241399000
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6173000
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2408000
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Assets Current
AssetsCurrent
160381000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
75046000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1456000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
615000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
157157000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
262000
CY2014Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
170279000
CY2014Q2 us-gaap Goodwill
Goodwill
43233000
CY2014Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5810000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
961000
CY2014Q2 us-gaap Assets
Assets
241399000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60862000
CY2014Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4223000
CY2014Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12014000
CY2014Q2 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
2097000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29785000
CY2014Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
12698000
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33426000
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15342000
CY2014Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
50901000
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4038000
CY2014Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
23393000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9468000
CY2014Q2 hstm Percentage Of Profit Or Loss Received From Collaborative Arrangement
PercentageOfProfitOrLossReceivedFromCollaborativeArrangement
0.50 pure
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41365000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27327000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27327000 shares
CY2013Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5503000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21968000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2311000
CY2013Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
13910000
us-gaap Payments For Software
PaymentsForSoftware
2013000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
-1501000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
318000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Assets Current
AssetsCurrent
147124000
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
181000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56212000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1614000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
776000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
149433000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
211000
CY2013Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
166888000
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8435000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17424000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
38168000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11389000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
212594000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6173000
CY2013Q4 us-gaap Goodwill
Goodwill
35746000
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5521000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
739000
CY2013Q4 us-gaap Assets
Assets
212594000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59537000
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3854000
CY2013Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
11077000
CY2013Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1392000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25314000
CY2013Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
8857000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31006000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8870000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
48659000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3365000
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
21631000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9038000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27529000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.407 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
11359000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
998000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26531000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
135000 shares
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
820000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4309000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
250000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
181000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000
us-gaap Stock Issued1
StockIssued1
0
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
51539000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-53000
us-gaap Operating Income Loss
OperatingIncomeLoss
7278000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
158000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7353000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6144000
us-gaap Net Income Loss
NetIncomeLoss
4362000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-53000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-20000
us-gaap Sales Revenue Net
SalesRevenueNet
61565000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1243000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-53000
us-gaap Costs And Expenses
CostsAndExpenses
54287000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9089000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1421000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1206000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5387000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
95000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
25391000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
13286000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10650000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
721000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-410000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
548000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5384000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1682000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3773000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
710000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
55947000
us-gaap Other Noncash Expense
OtherNoncashExpense
714000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2991000
hstm Revenues Related To Collaborative Arrangement
RevenuesRelatedToCollaborativeArrangement
1200000
hstm Expenses Related To Collaborative Arrangement
ExpensesRelatedToCollaborativeArrangement
1000000
dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001095565
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27975000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.423 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
22102000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
465000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27510000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
119000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
310000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
705000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4333000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
265000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12501000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000
us-gaap Stock Issued1
StockIssued1
2247000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
32046000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-53000
us-gaap Operating Income Loss
OperatingIncomeLoss
7408000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2247000
us-gaap Payments For Software
PaymentsForSoftware
2689000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
3841000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
261000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
152000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7476000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3558000
us-gaap Net Income Loss
NetIncomeLoss
4311000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
22000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
834000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-24000
us-gaap Sales Revenue Net
SalesRevenueNet
80825000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2423000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
22000
us-gaap Costs And Expenses
CostsAndExpenses
73417000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10592000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
2721000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
49000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14689000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
70000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
35663000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1325000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14199000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20826000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-520000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-992000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7840000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
462000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5123000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
834000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
29098000
us-gaap Other Noncash Expense
OtherNoncashExpense
728000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3165000
hstm Revenues Related To Collaborative Arrangement
RevenuesRelatedToCollaborativeArrangement
800000
hstm Expenses Related To Collaborative Arrangement
ExpensesRelatedToCollaborativeArrangement
900000
hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27649000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
927000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26722000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
135000 shares
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2379000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4106000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4134000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
2422000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43000
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
31919000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-43000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
27813000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4817000
CY2013Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
12871000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5450000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2778000
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1897000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1712000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28043000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
476000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27567000 shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
70000 shares
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2378000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4110000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4133000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
2364000
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14000
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
42476000
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
38366000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5361000
CY2014Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
18738000
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7251000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4294000
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2722000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
450000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1769000

Files In Submission

Name View Source Status
0001193125-14-289585-index-headers.html Edgar Link pending
0001193125-14-289585-index.html Edgar Link pending
0001193125-14-289585.txt Edgar Link pending
0001193125-14-289585-xbrl.zip Edgar Link pending
d753008d10q.htm Edgar Link pending
d753008dex311.htm Edgar Link pending
d753008dex312.htm Edgar Link pending
d753008dex321.htm Edgar Link pending
d753008dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstm-20140630.xml Edgar Link completed
hstm-20140630.xsd Edgar Link pending
hstm-20140630_cal.xml Edgar Link unprocessable
hstm-20140630_def.xml Edgar Link unprocessable
hstm-20140630_lab.xml Edgar Link unprocessable
hstm-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending